Emily M. Lee, PhD (she/her/hers)

NIH/NCATS, Maryland, United States

Emily Lee is a Functional Group Lead and Staff Scientist in the Early Translation Branch (ETB) within NCATS’ Division of Preclinical Innovation (DPI), where she leads the Advanced Models & Cell Discovery Assay group within the Antiviral Program for Pandemics (APP). Additionally, Lee is a senior staff scientist in NCATS’ 3-D Tissue Bioprinting Laboratory. She uses her diverse background in virology, high-throughput screening, and induced pluripotent stem cells and primary cells to lead her team to investigate, evaluate and implement new assay technologies to develop cost-effective physiologically relevant assays, including 3-D organotypic models, for drug discovery and development in the context of viral infections.

Disclosure information not submitted.

Presentation(s):

• Physiologically Relevant Models for Drug Discovery and Development

  Tuesday, February 6, 2024
  10:00 AM – 12:00 PM EST